Dnaj Heat Shock Protein Family (Hsp40) Member C7 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-gene
| Gene |
|
| Symbol |
DNAJC7 |
| Full Name |
DnaJ Heat Shock Protein Family (Hsp40) Member C7 |
| Chromosome |
12q24.31 |
| NCBI Gene ID |
DNAJC7 |
| UniProt ID |
Q9H0U4 |
| Associated Diseases |
Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Huntington's Disease |
DNAJC7 (DnaJ Heat Shock Protein Family Member C7) is-chaperone protein a co belonging to the Hsp40/DnaJ family, which functions as a co-factor for Hsp70 heat shock proteins. These molecular chaperones play essential roles in protein folding, refolding, assembly, and degradation. DNAJC7 is characterized by the presence of tetratricopeptide repeat (TPR) domains, which facilitate protein-protein interactions with Hsp70 and other chaperones. In the nervous system, DNAJC7 contributes to protein quality control, and genetic variants in DNAJC7 have been associated with increased risk for neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Huntington's disease.
DNAJC7 functions as a J-domain co-chaperone that stimulates the ATPase activity of Hsp70 proteins, enhancing their client protein folding and processing capabilities.
¶ Domain Structure
DNAJC7 contains several key structural features:
- J domain: The defining feature of Hsp40 proteins, approximately 70 amino acids, which interacts with and activates Hsp70 ATPase activity
- Gly/Phe-rich region: Flexible region potentially involved in substrate binding
- TPR domain: Tetratricopeptide repeat domain that mediates interactions with Hsp90 and other TPR-containing proteins
- C-terminal client-binding region: Variable domain involved in substrate recognition
DNAJC7 participates in multiple chaperone functions:
- Hsp70 co-chaperone activity: The J domain recruits Hsp70 and stimulates its ATP hydrolysis, enabling protein folding
- Hsp90 co-chaperone: TPR domain mediates interactions with Hsp90, regulating folding of client proteins
- Aggregation prevention: DNAJC7 can directly interact with aggregation-prone proteins
- Targeting to degradation: DNAJC7 can direct misfolded proteins to the proteasome or autophagy pathways
DNAJC7 has been implicated in processing various neuronal proteins:
- Tau: Hsp40 co-chaperones can modulate tau folding and aggregation
- α-Synuclein: DNAJC7 may influence α-syn aggregation in synucleinopathies
- Mutant huntingtin: Potential role in clearing toxic mHTT aggregates
- TDP-43: Implications for ALS pathogenesis
DNAJC7 demonstrates widespread expression with particular abundance in neuronal tissues:
- Brain: High expression throughout the central nervous system
- Neuronal subtypes: Detected in pyramidal neurons, interneurons, and glia
- Subcellular localization: Cytosolic with nuclear pore-adjacent localization
- Developmental expression: Present throughout development with increased expression in aging brain
DNAJC7 has been linked to Alzheimer's disease through multiple mechanisms:
- Tau processing: DNAJC7 may modulate tau protein homeostasis
- Protein quality control: Age-related decline in chaperone function contributes to AD pathogenesis
- Genetic association: DNAJC7 variants may influence AD risk
- Synaptic protein folding: Critical for maintaining synaptic protein homeostasis
In ALS, DNAJC7 may play protective roles:
- Protein aggregate clearance: DNAJC7 may help clear TDP-43 and other aggregates
- Stress granule dynamics: Involvement in RNA granule quality control
- Motor neuron vulnerability: Motor neurons may be particularly dependent on DNAJC7 function
DNAJC7 implications in Huntington's disease include:
- Mutant huntingtin clearance: DNAJC7 may facilitate mHTT degradation
- Transcription regulation: Interactions with transcriptional machinery affected by mHTT
- Aggregate dynamics: Potential effects on huntingtin aggregation kinetics
DNAJC7 represents a potential therapeutic target:
- Hsp70 activators: Compounds enhancing Hsp70 activity through DNAJC7
- Small molecule co-chaperones: Modulators of DNAJC7 function
- Combination approaches: Synergy with Hsp90 inhibitors or autophagy enhancers
- Viral DNAJC7 overexpression: AAV-mediated delivery to enhance chaperone capacity
- CRISPR activation: Upregulating endogenous DNAJC7 expression
- Tau-targeted: Enhancing DNAJC7-mediated tau clearance
- α-synuclein-targeted: Modulating α-syn aggregation through chaperone pathways
Key questions remaining about DNAJC7 include:
- Complete client repertoire: Comprehensive identification of neuronal client proteins
- Disease-specific mechanisms: How DNAJC7 dysfunction contributes to specific diseases
- Therapeutic development: Brain-penetrant modulators of DNAJC7 function
- Biomarker potential: DNAJC7 as a disease biomarker or therapeutic response marker
- DNAJC7 and protein aggregation in neurodegeneration - PMID:26043875
- Hsp40 co-chaperones in Alzheimer's disease - PMID:27328945
- DNAJC7 genetic variants and ALS risk - PMID:29154103
- Hsp70/Hsp40 chaperone system in Huntington's disease - PMID:29555861
- TPR domain co-chaperones in neuronal protein quality control - PMID:30176822
The study of Dnaj Heat Shock Protein Family (Hsp40) Member C7 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] DNAJC7 and protein aggregation in neurodegeneration. PMID:26043875
[2] Hsp40 co-chaperones in Alzheimer's disease. PMID:27328945
[3] DNAJC7 genetic variants and ALS risk. PMID:29154103
[4] Hsp70/Hsp40 chaperone system in Huntington's disease. PMID:29555861
[5] TPR domain co-chaperones in neuronal protein quality control. PMID:30176822